LevelJump Announces Non-Brokered Private Placement

• On 7 April 2026 LevelJump announced a non‑brokered private placement of up to 15 million common shares at C$0.05 per share, targeting gross proceeds of up to C$750,000.
• Closing is expected around 16 April 2026, subject to TSX‑V approval, with a four‑month hold period on the issued securities.
• Net proceeds are earmarked for general working capital; finders’ compensation may include cash and warrants (up to 7 % each).
• Insiders may participate; details pending.

• Capital need: The latest interim financials show a working‑capital deficiency of C$2.64 million and negative cash flow in the most recent quarter. Raising C$750k directly addresses part of this shortfall, reducing immediate liquidity risk.
• Dilution vs. price: The placement price (C$0.05) is below the current market price (C$0.06), implying modest dilution but also a discount that may attract investors seeking upside.
• Strategic relevance: No new assets or revenue streams are attached; the financing is purely a bridge to keep operations running while the company pursues organic growth and potential acquisitions (e.g., mammography expansion in Alberta).
• Comparative context: Earlier news focused on board reconstitution, shareholder requisitions, and modest equity incentives. None of those items provided cash. This financing is the first material infusion since the 2025‑10 reinstatement of trading, making it a material positive catalyst.

LevelJump operates diagnostic imaging clinics across Alberta and provides teleradiology services through its subsidiary Canadian Teleradiology Services. The flagship initiative is the organic expansion of clinic capacity (adding mammography, fluoroscopy, and pain‑management services) rather than large acquisitions.